Literature DB >> 16781056

Remote organ ischemic preconditioning protect brain from ischemic damage following asphyxial cardiac arrest.

Kunjan R Dave1, Isabel Saul, Ricardo Prado, Raul Busto, Miguel A Perez-Pinzon.   

Abstract

Ischemic preconditioning (IPC) is a phenomenon whereby an organ's adaptive transient resistance to a lethal ischemic insult occurs by preconditioning this organ with a sub-lethal/mild ischemic insult of short duration. Besides IPC, recent studies reported that a short sub-lethal ischemia and reperfusion in various organs can induce ischemic tolerance in another organ as well. This phenomenon is known as remote ischemic preconditioning (RPC). In the present study we tested the hypothesis that tolerance for ischemia can be induced in brain by RPC and IPC in a rat model of asphyxial cardiac arrest (ACA). RPC was induced by tightening the upper two-thirds of both hind limbs using a tourniquet for 15 or 30 min and IPC was induced by tightening bilateral carotid artery ligatures for 2 min. Eight minutes of ACA was induced 48 h after RPC or IPC. After 7 day of resuscitation, brains were extracted and examined for histopathological changes. In CA1 hippocampus, the number of normal neurons was 63% lower in cardiac-arrested rats as compared to the control group. The number of normal neurons in the 15 min RPC, 30 min RPC, and IPC groups was higher than the ACA group by 54, 70, and 67%, respectively. This study demonstrates that RPC and IPC are able to provide neuroprotection in a rat model of ACA. Besides direct application of RPC or IPC paradigms, the exploration of the mechanisms of observed neuroprotection by RPC and IPC may also lead to a possible therapy for CA patients.

Entities:  

Mesh:

Year:  2006        PMID: 16781056     DOI: 10.1016/j.neulet.2006.05.037

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  50 in total

Review 1.  Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use.

Authors:  Ulrich Dirnagl; Kyra Becker; Andreas Meisel
Journal:  Lancet Neurol       Date:  2009-04       Impact factor: 44.182

Review 2.  Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance.

Authors:  R Anne Stetler; Rehana K Leak; Yu Gan; Peiying Li; Feng Zhang; Xiaoming Hu; Zheng Jing; Jun Chen; Michael J Zigmond; Yanqin Gao
Journal:  Prog Neurobiol       Date:  2014-01-02       Impact factor: 11.685

3.  Ameliorative potential of conditioning on ischemia-reperfusion injury in diabetes.

Authors:  Ashish K Rehni; Kunjan R Dave
Journal:  Cond Med       Date:  2018-04-20

4.  Fatty acid methyl esters and Solutol HS 15 confer neuroprotection after focal and global cerebral ischemia.

Authors:  Hung Wen Lin; Isabel Saul; Victoria L Gresia; Jake T Neumann; Kunjan R Dave; Miguel A Perez-Pinzon
Journal:  Transl Stroke Res       Date:  2013-08-06       Impact factor: 6.829

5.  Preconditioning the human brain: practical considerations for proving cerebral protection.

Authors:  Sebastian Koch
Journal:  Transl Stroke Res       Date:  2010-09       Impact factor: 6.829

Review 6.  Neuroimmune Response in Ischemic Preconditioning.

Authors:  Ashley McDonough; Jonathan R Weinstein
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

7.  Should the STAIR criteria be modified for preconditioning studies?

Authors:  Michael M Wang; Guohua Xi; Richard F Keep
Journal:  Transl Stroke Res       Date:  2013-02       Impact factor: 6.829

8.  Limb remote-preconditioning protects against focal ischemia in rats and contradicts the dogma of therapeutic time windows for preconditioning.

Authors:  C Ren; X Gao; G K Steinberg; H Zhao
Journal:  Neuroscience       Date:  2007-12-15       Impact factor: 3.590

9.  Sleep Is Critical for Remote Preconditioning-Induced Neuroprotection.

Authors:  Allison J Brager; Tao Yang; J Christopher Ehlen; Roger P Simon; Robert Meller; Ketema N Paul
Journal:  Sleep       Date:  2016-11-01       Impact factor: 5.849

10.  Correction to: Neuroimmune Response in Ischemic Preconditioning.

Authors:  Ashley McDonough; Jonathan R Weinstein
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.